DONEVAN WESTERVELD: Open Payments
NPI 1588027239 · ST JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,294 in 94 payments from 18 companies in 2025. Trend: 2023 $1,941 · 2024 $1,669 · 2025 $2,294
Food & beverage: $2,117Travel & lodging: $177
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $372 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $325 |
| ABBVIE INC. | 14 | $253 |
| Lilly USA, LLC | 8 | $177 |
| Madrigal Pharmaceuticals | 8 | $143 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| Aimmune Therapeutics, Inc. | 6 | $132 |
| GENZYME CORPORATION | 5 | $120 |
| Janssen Biotech, Inc. | 7 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
Products named: INTERSTIM, DUPIXENT, OMVOH, REZDIFFRA, ENTYVIO, ZENPEP, TREMFYA, LINZESS.
Industry payments across FL — which companies pay providers there.
